A biotechnology company designing immunotherapies for solid tumor cancers with a patient's white blood cells is raising $80 million in its initial public offering or IPO.
https://sciencebusiness.technewslit.com/?p=45015
#News #Press #Science #Business #Biotechnology #Cancer #SolidTumor #Finance #Immunotherapy TCells #ClinicalTrial #Lymphocytes #Investment #IPO #ImmuneSystem #Licensing #VentureCapital
Precision T-Cell Solid Tumor Therapy Trial Underway
A clinical trial has begun testing a treatment for solid #tumor #cancers using engineered T-cells with proteins to attack specific tumor cells, but also avoid healthy cells.
https://sciencebusiness.technewslit.com/?p=44842
#News #Science #Business #ClinicalTrial #Biotechnology #Tcells #Immunotherapy #SolidTumor #PrecisionMedicine #CompanionDiagnostic
What if we could trace #cytotoxic #Tcells throughout the human body before and during #cancer #immunotherapy?
Researchers at the University of Groningen have used a CD8-specific positron emission tomography (#PET) tracer in a phase 1/2 clinical trial. Patients with solid tumors were imaged before and ~30 days after starting treatment with #antibodies against PD-L1, PD-1, and/or CTLA-4.
Article in Nature Medicine: https://www.nature.com/articles/s41591-022-02084-8
A CD8-specific, one-armed antibody positron emission tomography tracer enables the visualization of the immune response in patients with solid tumors before and after starting immunotherapy.
Alan Kotok
Christian Tidona